Botulinum toxin type A applications for masticatory myofascial pain and trigeminal neuralgia: what is the evidence regarding adverse effects?

被引：18

作者：

Canales, Giancarlo De la Torre ^{[1
]}

Poluha, Rodrigo Lorenzi ^{[1
]}

Lora, Victor Munoz ^{[2
]}

Araujo Oliveira Ferreira, Dyna Mara ^{[1
]}

Stuginski-Barbosa, Juliana ^{[1
]}

Bonjardim, Leonardo Rigoldi ^{[1
]}

Del Bel Cury, Altair Antoninha ^{[2
]}

Rodrigues Conti, Paulo Cesar ^{[1
]}

机构：

[1] Univ Sao Paulo, Bauru Sch Dent, Dept Prosthodont, Bauru Orofacial Pain Grp, Bauru, SP, Brazil

[2] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Prosthodont, Piracicaba, Brazil

来源：

CLINICAL ORAL INVESTIGATIONS | 2019年 / 23卷 / 09期

基金：

巴西圣保罗研究基金会;

关键词：

Botulinum toxins; Adverse effects; Muscle weakness; Muscle atrophy; Bone loss; Muscle paralysis; DOUBLE-BLIND; MUSCLES; INJECTIONS; EFFICACY; BONE; NEUROTOXINS;

D O I：

10.1007/s00784-019-03026-4

中图分类号：

R78 [口腔科学];

学科分类号：

1003 ;

摘要：

Objectives The objective of the study was to conduct a systematic review of literature assessing botulinum toxin type A (BoNT-A) safety and adverse effects in the treatment of myofascial pain (MFP) and trigeminal neuralgia (TN). Materials and methods The search for articles by two specific researchers involved the PubMed, EMBASE, Web of Science, and Scopus databases. Specific terms were used, and no publication time and language restrictions were applied. Clinical trials that investigated the effects of BoNT-A among participants with myofascial pain in masticatory muscles or trigeminal neuralgia were considered eligible for this systematic review. Data for each study were extracted and analyzed according to a PICO-like structured reading. Results The search strategy provided 436 citations. After analysis, 16 citations were included, seven for MFP and nine for TN. In all studies, BoNT-A was well tolerated and improved pain. The most common adverse effects were temporary regional weakness, tenderness over the injection sites, and minor discomfort during chewing. Most studies reported a spontaneous resolution of adverse effect. Conclusions It can be concluded that BoNT-A treatment is well tolerated, since minor adverse effects were the most frequently reported; however, it is recommended that future studies aim to assess the safety and possible adverse effects of multiples applications or high doses of this treatment.

引用

页码：3411 / 3421

页数：11

共 49 条

[1] Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections [J].

Abboud, W. A. ;

Hassin-Baer, S. ;

Joachim, M. ;

Givol, N. ;

Yahalom, R. .

INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2017, 46 (11) :1417-1423

[2] Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report [J].

Bohluli, Behnam ;

Motamedi, Mohammad Hosein Kalantar ;

Bagheri, Shahrokh C. ;

Bayat, Mohammad ;

Lassemi, Eshagh ;

Navi, Fina ;

Moharamnejad, Nima .

ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2011, 111 (01) :47-50

[3] Botulinum toxin in the treatment of trigeminal neuralgia 6-Month follow-up [J].

Boru, Ulku Turk ;

Duman, Arda ;

Boluk, Gem ;

Duman, Llsanem Coskun ;

Tasdemir, Mustafa .

MEDICINE, 2017, 96 (39)

[4] Efficacy of Botulinum Toxin Type A in Trigeminal Neuralgia in a South Asian Cohort [J].

Caldera, Manjula Chandragomi ;

Senanayake, Sameera Jayan ;

Perera, Sujith Priyankara ;

Perera, Nadeeke Nidhan ;

Gamage, Ranjanie ;

Gooneratne, Inuka Kishara .

JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2018, 9 (01) :100-105

[5]

Colhado Orlando Carlos Gomes, 2009, Rev. Bras. Anestesiol., V59, P366

[6] Botulinum toxin type A injections:: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases [J].

Coté, TR ;

Mohan, AK ;

Polder, JA ;

Walton, MK ;

Braun, MM .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (03) :407-415

[7]

De la Torre Canales G, 2017, CLIN ORAL INVESTIG

[8] Mechanisms of action [J].

Dressler, D ;

Saberi, FA ;

Barbosa, ER .

ARQUIVOS DE NEURO-PSIQUIATRIA, 2005, 63 (01) :180-185

[9]

Ernberg M, 2011, PAIN, V152, P1988, DOI 10.1016/j.pain.2011.03.036

[10] Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis [J].

Finnerup, Nanna B. ;

Attal, Nadine ;

Haroutounian, Simon ;

McNicol, Ewan ;

Baron, Ralf ;

Dworkin, Robert H. ;

Gilron, Ian ;

Haanpaa, Maija ;

Hansson, Per ;

Jensen, Troels S. ;

Kamerman, Peter R. ;

Lund, Karen ;

Moore, Andrew ;

Raja, Srinivasa N. ;

Rice, Andrew S. C. ;

Rowbotham, Michael ;

Sena, Emily ;

Siddall, Philip ;

Smith, Blair H. ;

Wallace, Mark .

LANCET NEUROLOGY, 2015, 14 (02) :162-173

← 1 2 3 4 5 →